A. Fisseler-Eckhoff (Wiesbaden, Germany), A.-P. Meert (Brussels, Belgium)
Targeting of STAT3 and survivin with TG101209, a novel JAK2 inhibitor, enhances radiotherapy in lung cancer models L. Moretti, Y. Sun, B. Lu (Nashville, United States Of America)
| |
LSC 2010 Abstract: Macrophages promote proliferation of lung cancer cell by activation of NF-κB D. Li, C. Herr, R. Bals (Marburg, Germany)
| |
Micro-RNA in bronchial lavage of lung cancer patients – First feasibility study B. Schmidt, M. Haug, S. Weickmann, C. Witt, M. Fleischhacker (Halle, Berlin, Germany)
| |
Down regulation of type V collagen triggers angiogenesis and immune response disfunction in lung cancer microenvironment A. Ruppert, O. Bianchi, P. Souza, E. R. Parra, G. Noleto, M. Atanazio, A. Ab´Saber, W. Teodoro, T. Takagaki, N. Yoshinari, V. L. Capelozzi (Brazil)
| |
Molecular signatures of exposure and subtype in lung cancer tissue from uranium miners B. Pesch, S. Casjens, I. Stricker, D. Westerwick, T. Wiethege, A. Tannapfel, T. Brüning, G. Johnen (Bochum, Germany)
| |
Why is allograft formation in SCID mice slow in lung adenocarcinoma cell line with EGFR activating mutation? N. Nukiwa, M. Xie, T. Fukuhara, C. Treda, T. Kikuchi, M. Ebina, T. Nukiwa (Sendai, Japan)
| |
Blocking VEGF does not induce proapoptotic effects in the NSCLC cell line A549 C. Wohlkoenig, K. Leithner, A. Hrzenjak, A. Olschewski, H. Olschewski (Austria)
| |
Tiotropium inhibits growth of squamous cell lung carcinoma (SCC) cell lines in vitro and also inhibits SCC growth in vivo in nude mice by inhalation P. Song, A. S. Olivas, E. R. Spindel (Beaverton, United States Of America)
| |